Private Capital Group, LLC Coherus Bio Sciences, Inc. Transaction History

Private Capital Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$14.43 - $19.16 $34,372 - $45,639	-2,382 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$11.67 - $22.53 $19,733 - $38,098	1,691 Added 244.72%	2,382 $39,000
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $20,788 - $27,204	-1,273 Reduced 64.82%	691 $12,000
Q3 2019 Nov 13, 2019	BUY	$16.3 - $23.37 $32,013 - $45,898	1,964 New	1,964 $40,000

148

82.9M

184K

255K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $108M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.